Patrick Soon-Shiong (original) (raw)
- Medical doctor Patrick Soon-Shiong invented the cancer drug Abraxane. It became a blockbuster thanks to its efficacy against pancreatic cancer.
- He sold his drug companies Abraxis in 2010 and American Pharmaceutical Partners in 2008 for a combined $9.1 billion.
- He took his cancer drug maker NantKwest public in 2015 and his biotech startup NantHealth public in 2016.
- He owns NantWorks, a network of health startups, and has stakes in media firm Tribune Publishing and the Los Angeles Lakers.
- He bought the Los Angeles Times and San Diego Tribune for $500 million in June 2018.
- In May 2020, Soon-Shiong's ImmunityBio was selected for the federal government's "Operation Warp Speed" to help quickly develop a Covid-19 vaccine.
Wealth History
HOVER TO REVEAL NET WORTH BY YEAR
Forbes Lists
Personal Stats
Age
72
Source of Wealth
Pharmaceuticals, Self Made
9
2
Residence
Los Angeles, California
Citizenship
United States
Marital Status
Married
Children
2
Education
Master of Science, University of British Columbia; Bachelor of Arts/Science, University of Witwatersrand; Medical Doctor, University of Witwatersrand
Did you know
Soon-Shiong graduated from high school at age 16 and became a doctor at 23.
Soon-Shiong was born in South Africa to Chinese immigrants.
In Their Own Words
My quest was and is to improve the quality of life through science. That is what drove me then, and that is what is driving me now.
Patrick Soon-Shiong
Related People & Companies